attention deficit hyperactivity disorder. Disturbance of activity and attention
Conditions
Interventions
Intervention 1: Bupropion, 75 milligram tablets, orally, two times a day, Morning and afternoon. Intervention 2: Methylphenidate (Ritalin) tablets, 10 mg, orally, two times a day, morning and evening,
Treatment - Drugs
Bupropion, 75 milligram tablets, orally, two times a day, Morning and afternoon
Methylphenidate (Ritalin) tablets, 10 mg, orally, two times a day, morning and evening, based on weight 0.3-0.8 mg/kg
Sponsors
Research vice chancellor of Mashad university of medical sciences
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1-Children 6 to 12 years old with diagnosis of ADHD on the basis of DSM-IV-TR; 2-children without MR (IQ>70); 3-children without medical and neurologic problems specially with a history of epilepsy; 4-children without eating disorders (because of being prone to seizure due to bupropion); 5-agreement of parents in research participation; 6-the child that does not have the history of using Methyl phenidate and Bupropion and other psychiatric drugs. Exclusion criteria: 1-disagreement of parents during the research; 2-existance of severe side effects like neurologic disorders such as convulsion in curing groups.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of children (C-GAS). Timepoint: Before intervention, the fourth week and eighth week after the start of intervention. Method of measurement: Teacher and parent questionnaire.;Attention Deficit, hyperactivity Disorder Scale. Timepoint: Before intervention, the fourth week and eighth week after the start of intervention. Method of measurement: Teacher and parent questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects of bupropion. Timepoint: the fourth week and eighth week after the start of intervention. Method of measurement: Questionnaire check list.;Side effects of stimulant drugs. Timepoint: the fourth week and eighth week after the start of intervention. Method of measurement: Questionnaire check list. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohsen Pasandideh
Mashad university of medical sciences
Outcome results
None listed